260 related articles for article (PubMed ID: 25750554)
1. Applications of systems approaches in the study of rheumatic diseases.
Kim KJ; Lee S; Kim WU
Korean J Intern Med; 2015 Mar; 30(2):148-60. PubMed ID: 25750554
[TBL] [Abstract][Full Text] [Related]
2. [Institute of Rheumatology and progress of antirheumatic therapy].
Sigidin IaA
Vestn Ross Akad Med Nauk; 1998; (12):7-9. PubMed ID: 9987950
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic targeting of B cells for rheumatic autoimmune diseases.
Engel P; Gómez-Puerta JA; Ramos-Casals M; Lozano F; Bosch X
Pharmacol Rev; 2011 Mar; 63(1):127-56. PubMed ID: 21245206
[TBL] [Abstract][Full Text] [Related]
4. Disease markers and new therapeutics. Dual objectives of genetics in rheumatology.
Nepom GT
Rheum Dis Clin North Am; 1992 Nov; 18(4):719-27. PubMed ID: 1455044
[TBL] [Abstract][Full Text] [Related]
5. The possible clinical application of pharmacogenetics in rheumatology.
Ferraccioli G
J Rheumatol; 2003 Dec; 30(12):2517-20. PubMed ID: 14719186
[No Abstract] [Full Text] [Related]
6. Pharmacogenomics in pediatric rheumatology.
Becker ML
Curr Opin Rheumatol; 2012 Sep; 24(5):541-7. PubMed ID: 22732686
[TBL] [Abstract][Full Text] [Related]
7. Information technology in rheumatology.
Pincus T; Braun J; Kavanaugh A; Ravelli A; Smolen JS
Clin Exp Rheumatol; 2016; 34(5 Suppl 101):1. PubMed ID: 27762207
[No Abstract] [Full Text] [Related]
8. Network analysis in the investigation of chronic respiratory diseases. From basics to application.
Diez D; Agustí A; Wheelock CE
Am J Respir Crit Care Med; 2014 Nov; 190(9):981-8. PubMed ID: 25254605
[TBL] [Abstract][Full Text] [Related]
9. The National Data Bank for Rheumatic Diseases (NDB).
Michaud K
Clin Exp Rheumatol; 2016; 34(5 Suppl 101):S100-S101. PubMed ID: 27762196
[TBL] [Abstract][Full Text] [Related]
10. Genetic characteristics of rheumatic patients developing inflammatory skin lesions induced by biologic therapy.
Almirall M; Docampo E; Estivill X; Maymó J
Reumatol Clin; 2015; 11(2):126-7. PubMed ID: 25218411
[No Abstract] [Full Text] [Related]
11. Advances in targeted therapies XII. Preface.
Breedveld FC; Kalden JR; Smolen JS
Ann Rheum Dis; 2011 Mar; 70 Suppl 1():i1. PubMed ID: 21339210
[No Abstract] [Full Text] [Related]
12. Setting the research agenda for future clinical trials on the use of biologics in rheumatology.
Silman A; Rudkin S; Walley T
Rheumatology (Oxford); 2011 Aug; 50(8):1356-7. PubMed ID: 21118870
[No Abstract] [Full Text] [Related]
13. [A short history of anti-rheumatic therapy--VII. Biological agents].
Pasero G; Marson P; Gatto B
Reumatismo; 2011 Nov; 63(3):185-94. PubMed ID: 22257920
[TBL] [Abstract][Full Text] [Related]
14. [Experimental rheumatology--on the way to a fundamental understanding of rheumatic diseases].
Radbruch A
Z Rheumatol; 2005 Sep; 64(6):367-9. PubMed ID: 16184342
[No Abstract] [Full Text] [Related]
15. Review: basics of drug development in rheumatology.
Mina-Osorio P
Arthritis Rheumatol; 2015 Oct; 67(10):2581-90. PubMed ID: 26138901
[No Abstract] [Full Text] [Related]
16. Go, go, GoTreatIT!
Sokka T
Clin Exp Rheumatol; 2016; 34(5 Suppl 101):S91-S95. PubMed ID: 27762202
[TBL] [Abstract][Full Text] [Related]
17. [Personalized medicine in rheumatology].
Szekanecz Z
Orv Hetil; 2013 Mar; 154(13):483-96. PubMed ID: 23524232
[TBL] [Abstract][Full Text] [Related]
18. Recent advances in pediatric rheumatology: July to September 2017.
Pilania RK; Bhattarai D; Singh S
Int J Rheum Dis; 2018 May; 21(5):1135-1137. PubMed ID: 29611302
[No Abstract] [Full Text] [Related]
19. Recent advances in pediatric rheumatology: October - December 2017.
Pilania RK; Bhattarai D; Singh S
Int J Rheum Dis; 2018 May; 21(5):1138-1141. PubMed ID: 29611300
[No Abstract] [Full Text] [Related]
20. Recent advances in pediatric rheumatology: April to June 2017.
Guleria S; Pilania RK; Singh S
Int J Rheum Dis; 2018 Feb; 21(2):546-548. PubMed ID: 29205939
[No Abstract] [Full Text] [Related]
[Next] [New Search]
